Clinical Trials Logo

Stress Disorders, Traumatic clinical trials

View clinical trials related to Stress Disorders, Traumatic.

Filter by:

NCT ID: NCT05592652 Recruiting - Clinical trials for Post Traumatic Stress Disorder

Identification of the Clinical Specificities of Complex Posttraumatic Stress Disorder

IDPLEX
Start date: January 25, 2023
Phase: N/A
Study type: Interventional

Identification of the clinical specificities of complex post-traumatic stress disorder post-traumatic stress disorder

NCT ID: NCT05591625 Recruiting - Critical Illness Clinical Trials

Eye Movement Desensitisation and Reprocessing (EMDR) to Improve Mental Health Following Intensive Care Admission

EMERALD
Start date: February 20, 2023
Phase: N/A
Study type: Interventional

The goal of this multi-centre, randomised, pilot feasibility study is to assess the feasibility of recruiting intensive care survivors, with symptoms of traumatic stress, to a study evaluating the use of eye movement desensitisation and reprocessing (EMDR). The main purpose is to determine whether it is feasible and acceptable to patients, clinicians and researchers. In addition, this study aims to identify design criteria that may be of use in a subsequent randomised controlled trial of clinical effectiveness. Participants will: - be recruited at hospital discharge - undergo a psychological assessment at 2-3 months post-hospital discharge - Those exhibiting symptoms of post-traumatic stress disorder (PTSD), will be randomised (1:1) to receive either usual care or usual care plus EMDR - Participants who do not exhibit PTSD symptoms at the 2-3 month assessment will enter a light-touch observation arm. - All participants will repeat the psychological assessment 12-months after hospital discharge. Feasibility parameters; recruitment, adherence, retention and safety data. Primary clinical outcomes; change in PTSD symptoms between 2-3 months and 12-months. The investigators will undertake a qualitative process evaluation using clinical ethnography and reported according to the Theoretical Framework of Acceptability.

NCT ID: NCT05579717 Recruiting - Clinical trials for Posttraumatic Stress Disorder

Examining EAL for PTSD

EAL
Start date: March 1, 2022
Phase: N/A
Study type: Interventional

This RCT will evaluate the efficacy of Equine Assisted Learning for reducing PTSD symptoms in public safety personnel (e.g., fire fighters, police, nurses, etc.).

NCT ID: NCT05565352 Enrolling by invitation - Clinical trials for Major Depressive Disorder

Observation of Ketamine Treatment Safety and Tolerability in Adult Psychiatry Clinic Medical University of Gdańsk Inpatients

KetGD
Start date: September 1, 2022
Phase:
Study type: Observational

Adult Psychiatry Clinic Medical University of Gdańsk (MUG) is a healthcare facility that provides ketamine treatment to adult patients suffering from mental health conditions. The Clinic especially treats individuals suffering from treatment-resistant disorders, like - mood disorders, anxiety disorders, obsessive-compulsive and related disorders, trauma and stressor-related disorders, somatic symptom and related disorders, and dissociative disorders. Herein, this naturalistic observation aims to look at the safety and tolerability of ketamine treatment to further develop the understanding of ketamine in the use of psychiatry.

NCT ID: NCT05563805 Recruiting - Depression Clinical Trials

Exploring Virtual Reality Adventure Training Exergaming

V-RATE
Start date: September 7, 2022
Phase: N/A
Study type: Interventional

The current project aims to design and implement an 8-week Virtual Reality Adventure Therapy Exergaming (V-RATE) intervention focused on women veterans. A randomized controlled trial using a repeated measure design with a 1-month follow-up assessment will be employed to examine effects on physical and mental health outcomes.

NCT ID: NCT05562973 Withdrawn - Clinical trials for Post-Traumatic Stress Disorder

Safety and Tolerability of Psilocybin in Post-Traumatic Stress Disorder

Start date: January 2025
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the safety, tolerability, and potential efficacy of psilocybin-assisted psychotherapy to reduce post-traumatic stress disorder (PTSD) severity in a sample of individuals with PTSD.

NCT ID: NCT05560854 Completed - Clinical trials for Post Traumatic Stress Disorder

A Feasibility Study of Internet Delivered Prolonged Exposure

Start date: October 18, 2022
Phase: N/A
Study type: Interventional

The primary objective with this study is to investigate the feasibility and acceptability of ten weeks of internet delivered prolonged exposure delivered through a digital platform with therapist support. The secondary objective is to investigate preliminary effects of internet delivered prolonged exposure in terms of reducing symptoms of post-traumatic stress, depression and increase quality of life.

NCT ID: NCT05560113 Recruiting - Clinical trials for Post-Traumatic Stress Disorder

Disrupting Fear-based Memory Consolidation

Start date: November 28, 2022
Phase: N/A
Study type: Interventional

This project represents a unique collaborative opportunity to pursue the essential proof-of-principle demonstration that non-invasive interference of sensory cortical memory consolidation shortly after an emotional experience can attenuate the cued fear response and potentially reduce the risk of developing post-traumatic stress disorder (PTSD). If successful, the study results would anchor a potential advance in the treatment of patients after a traumatic event and seed future animal and clinical studies of emotional sensory cortical memory consolidation to reduce the prevalence and negative sequelae of PTSD.

NCT ID: NCT05554094 Recruiting - PTSD Clinical Trials

Psilocybin for the Treatment of Veterans With Post-Traumatic Stress Disorder

Start date: January 1, 2023
Phase: Phase 2
Study type: Interventional

The primary aim of this study is to assess the safety and efficacy of psilocybin-assisted therapy in the treatment of post-traumatic stress disorder in United States military Veterans.

NCT ID: NCT05553249 Enrolling by invitation - Clinical trials for Post Traumatic Stress Disorder

Written Exposure Therapy for PTSD in a Virtual, Group-based Format

Start date: November 14, 2022
Phase:
Study type: Observational

The purpose of this study is to examine whether Written Exposure Therapy (WET) can be effectively delivered virtually and in a group format for the treatment of Post-Traumatic Stress Disorder in a military and police population. The objective of this study is to assess treatment feasibility and acceptability, drop out rates, changes in severity of trauma-related symptoms and symptoms of depression, quality of life, and the need for further trauma-focused treatment (TFT) for the the delivery of WET as a virtual, group based intervention.